Indian Emulsifiers Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 6 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹78 Cr
For FY '26, the company expects revenue growth upward of 100%, with projections between 150% to 200% growth compared to FY '25. FY '26 revenue growth expected upward of 100%, targeting around ₹250 crore (Page 6, 7, 21).
From Indian Emulsifiers Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹40.4
Market Cap
₹78 Cr
P/E Ratio
4.8
How does Indian Emulsifiers Ltd rank in Chemicals & Petrochemicals?
Compare Indian Emulsifiers Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
📊 Revenue & Sales Performance
- →For FY '26, the company expects revenue growth upward of 100%, with projections between 150% to 200% growth compared to FY '25.
- →Capacity expansion planned to reach approximately 18,000 metric tonnes by mid-next year, potentially representing over 250% increase compared to last year.
- →New capacities coming online and approvals for newer products and customers underpin this growth visibility.
- →The southern emulsifier Australian subsidiary is projected to contribute about ₹75 crores in revenue over the next two to three years.
- →The company anticipates maintaining high double-digit growth rates for the next 3 years, driven by expanded capacity and market access.
- →Product diversification and multiple verticals contribute to sustained growth potential.
- →Volume increases, new product commercialization, and growing customer base are key revenue drivers, rather than price hikes.
📈 Profitability & Margins
- →FY '26 revenue growth expected upward of 100%, targeting around ₹250 crore (Page 6, 7, 21).
- →Sustained high growth trajectory over next 2-3 years driven by capacity expansions and new product commercialization (Pages 3, 18, 21, 24).
- →EBITDA margins expected to remain stable in the 19%-22% range (Pages 7, 18, 24).
- →PAT margins to be maintained at similar levels to EBITDA margins, around 19%-22% (Page 24).
- →Capacity utilization improvements and new capacities coming online to support growth and profitability (Pages 7, 9, 21, 24).
- →Australian subsidiary targets revenue contribution of about ₹75 crore over the next 3 years, supporting international footprint and diversification (Pages 3, 11, 24).
- →EPS is expected to improve in line with revenue and profit growth, supported by operating leverage and efficient capacity utilization.
🏗️ Capital Expenditure Plans
- →Current CapEx involves expansion to add 400 to 500 metric tons capacity, funded by roughly ₹17-18 crores, primarily from IPO proceeds and rights issue.
- →Phase one expansion targets early to middle of next year for partial capacity coming online; full utilization expected within 2-3 months after commissioning.
- →Additional land acquisition adjacent to existing Lote Parshuram facility to support capacity expansion up to 1,000 metric tons.
- →Phase two and further expansions envisioned to raise capacity beyond 1,000 metric tons, with debt funding considered approximately 10-14 months post-phase one.
- →CapEx mix planned as combination of equity (used in phase one) and debt (planned for future phases).
- →Strategic investment includes ramping up R&D team (~12 members) to support product development.
- →Australian subsidiary in initial stages, targeting revenue of about ₹75 crores in 2-3 years as part of strategic geographic expansion.
💰 Fundraising & Capital Structure
- →Currently, there are no immediate plans for equity dilution beyond the recent rights issue.
- →The company prefers to use a debt component for additional capital expenditure (CapEx) in the near future.
- →For the ongoing expansion (phase one), funding is through equity, specifically the recent rights issue.
- →For phase two and further expansions (after approximately 10-14 months), the company plans to consider debt financing.
- →The existing banking relationships and sanctioned credit lines are active for debt utilization.
- →Promoters will participate in the rights issue, but exact amounts are undisclosed.
- →The rights issue price was set as per SEBI and exchange norms, with some discount beneficial to shareholders.
📋 Order Book & Pipeline
- →The company has clear visibility on growth for the next 2-3 years based on existing market access and order book.
- →The order book includes incremental volume allocations at existing customers, approval of new products at existing customers, and onboarding of new customers.
- →For the Australian subsidiary, initial orders have been executed recently, with expected revenue of about ₹75 crores over the next 2-3 years.
- →Customer approvals are ongoing, with two customers already contributing and others in the final stages of approval.
- →Agreements are mostly on monthly price revisions, with some large customers having agreements up to 3 months.
- →The focus is on scaling capacity utilization alongside incoming orders to meet projected revenue growth.
Key Metrics
Frequently Asked Questions
What were Indian Emulsifiers Ltd Q2 FY26 results?
For FY '26, the company expects revenue growth upward of 100%, with projections between 150% to 200% growth compared to FY '25. FY '26 revenue growth expected upward of 100%, targeting around ₹250 crore (Page 6, 7, 21).
What is Indian Emulsifiers Ltd share price analysis?
Indian Emulsifiers Ltd currently shows a neutral. The stock trades at a P/E of 4.8 with a market cap of ₹78 Cr. Investors should review the full earnings analysis for detailed insights.
Is Indian Emulsifiers Ltd planning capital expenditure?
Current CapEx involves expansion to add 400 to 500 metric tons capacity, funded by roughly ₹17-18 crores, primarily from IPO proceeds and rights issue.
Keep Indian Emulsifiers Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.